Index
RUT
Market Cap
1.71B
Enterprise Value
1.83B
Income
-2.92M
Sales
408.45M
Book/sh
6.34
Cash/sh
1.21
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
1576
IPO
Dec 11, 2020
P/E
-
Forward P/E
28.21
PEG
112.86
P/S
4.18
P/B
1.77
P/C
9.28
P/FCF
21.25
EV/EBITDA
19.84
EV/Sales
4.47
Quick Ratio
2.55
Current Ratio
2.55
Debt/Eq
0.31
LT Debt/Eq
0.31
Option/Short
Yes / Yes
EPS (ttm)
-0.02
EPS next Y
0.40
EPS next Q
0.09
EPS this Y
-22.70%
EPS next Y
16.71%
EPS next 5Y
0.25%
EPS past 3/5Y
- 50.19%
Sales past 3/5Y
7.66% 11.45%
EPS Y/Y TTM
-134.07%
Sales Y/Y TTM
0.66%
EPS Q/Q
642.62%
Sales Q/Q
-10.81%
Insider Own
36.33%
Insider Trans
0.00%
Inst Own
77.77%
Inst Trans
0.17%
ROA
-1.31%
ROE
-1.89%
ROIC
-0.23%
Gross Margin
48.49%
Oper. Margin
4.63%
Profit Margin
-0.72%
SMA20
13.86%
SMA50
24.86%
SMA200
54.28%
Trades
Shs Outstand
152.50M
Shs Float
97.12M
52W High
12.29 -8.87%
52W Low
4.45 151.69%
Volatility
5.53% 5.51%
ATR (14)
0.51
RSI (14)
69.47
Beta
1.34
Rel Volume
0.95
Avg Volume
2.88M
Volume
2,727,048
Perf Week
11.00%
Perf Month
21.74%
Perf Quarter
38.27%
Perf Half Y
82.71%
Perf YTD
27.13%
Perf Year
-3.28%
Perf 3Y
-8.72%
Perf 5Y
-72.89%
Perf 10Y
-
Prev Close
11.48
Price
11.20
Change %
-2.44%
Analysts 14 incl. previous ratings
Rating Distribution 6 Buy · 8 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Mar 06, 2026 Downgrade B Barclays
Overweight → Equal Weight $8 -28.6% Feb 27, 2026 Downgrade C Craig Hallum
Buy → Hold $10 -10.7% Jan 06, 2026 Upgrade L Leerink Partners
Market Perform → Outperform $13 +16.1% Nov 21, 2025 Initiated R Rothschild & Co Redburn
Buy $10 -10.7% Nov 13, 2025 Initiated B BMO Capital Markets
Market Perform $9 -19.6% Sep 29, 2025 Initiated C Craig Hallum
Buy $16 +42.9% Jul 03, 2025 Resumed M Morgan Stanley
Equal-Weight $16 +42.9% May 08, 2025 Upgrade B Barclays
Equal Weight → Overweight $14 +25.0% Feb 27, 2025 Initiated T TD Cowen
Buy $16 +42.9% Sep 27, 2024 Upgrade U UBS
Neutral → Buy $16 +42.9% Apr 10, 2024 Upgrade K KeyBanc Capital Markets
Sector Weight → Overweight $23 +105.4% Apr 04, 2024 Initiated J JMP Securities
Mkt Perform Feb 26, 2024 Initiated L Leerink Partners
Market Perform $19 +69.6% Dec 07, 2023 Initiated U UBS
Neutral $17 +51.8% Dec 05, 2023 Initiated K KeyBanc Capital Markets
Sector Weight Aug 22, 2023 Downgrade J Jefferies
Buy → Hold $24.50 → $17 +51.8% Aug 10, 2023 Downgrade W William Blair
Outperform → Mkt Perform Apr 12, 2023 Initiated S Stephens
Overweight $28 +150.0% Apr 03, 2023 Downgrade B Barclays
Overweight → Equal Weight $25 +123.2% Dec 14, 2022 Downgrade R Robert W. Baird
Outperform → Neutral $17 → $19 +69.6%
Show Previous Ratings
Oct-28-26 01:23PM
Oct-26-26 08:00AM
Oct-08-26 07:58PM
Aug-04-26 07:00AM
Jul-23-26 09:05AM
04:15PM
Loading…
Jul-15-26 04:15PM
Jul-07-26 08:54AM
08:00AM
Jul-06-26 08:55AM
08:45AM
Jun-17-26 04:30PM
Jun-16-26 08:45AM
May-18-26 04:15PM
May-12-26 03:03AM
May-11-26 10:17AM
06:25AM
Loading…
06:25AM
May-07-26 08:00AM
Apr-22-26 07:00AM
Apr-09-26 04:15PM
Mar-07-26 11:02PM
Mar-03-26 08:00AM
Feb-27-26 08:30AM
Feb-26-26 04:08PM
12:06PM
08:15AM
06:00AM
Feb-10-26 02:56PM
Jan-29-26 08:30AM
Jan-27-26 07:38AM
Dec-12-25 10:15AM
06:00AM
Loading…
Dec-11-25 06:00AM
Dec-09-25 03:33PM
Dec-08-25 12:20PM
09:55AM
Nov-07-25 12:13AM
Nov-06-25 06:55PM
04:15PM
Nov-04-25 10:00AM
08:00AM
Oct-31-25 08:00AM
Oct-30-25 04:15PM
10:00AM
Oct-20-25 08:00AM
Oct-10-25 08:00AM
Oct-02-25 09:13AM
Sep-04-25 08:00AM
Sep-02-25 04:15PM
Aug-07-25 03:28PM
Aug-06-25 06:00PM
04:15PM
Aug-04-25 02:00AM
Jul-31-25 04:15PM
10:00AM
Jul-30-25 10:00AM
Jul-29-25 08:25AM
Jul-18-25 08:38AM
Jul-15-25 01:56PM
Jul-11-25 12:10PM
Jul-10-25 12:39AM
Jul-09-25 04:15PM
Jul-08-25 12:05PM
08:00AM
Jun-28-25 09:10AM
Jun-20-25 08:25AM
May-23-25 09:17AM
May-06-25 08:31AM
(Thomson Reuters StreetEvents)
-11.03%
03:09AM
May-05-25 07:22PM
05:45PM
04:15PM
Apr-29-25 04:15PM
10:01AM
Apr-28-25 10:00AM
Apr-21-25 08:00AM
Apr-16-25 12:10PM
Apr-15-25 12:40AM
Apr-14-25 08:15AM
08:00AM
Apr-12-25 06:45PM
02:10AM
Apr-11-25 01:15PM
10:04AM
Apr-02-25 12:49PM
Apr-01-25 08:00AM
Mar-06-25 07:58PM
Mar-05-25 04:15PM
Feb-27-25 07:59AM
(Thomson Reuters StreetEvents)
02:28AM
Feb-26-25 06:45PM
04:15PM
Feb-14-25 01:12PM
Jan-29-25 04:15PM
Jan-24-25 12:48PM
Jan-15-25 07:55AM
Jan-02-25 04:15PM
Dec-06-24 10:02AM
Dec-02-24 04:15PM
Nov-13-24 09:29AM
Nov-07-24 10:38AM
(Thomson Reuters StreetEvents)
02:27AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Pedersen Leif E Officer Sep 03 '26 Proposed Sale 8.32 36,066 300,069 Sep 03 11:09 AM Anhalt Rona Chief Human Resources Officer Jun 01 '26 Option Exercise 0.00 7,147 0 19,030 Jun 02 05:15 PM Corcoran Daniel SVP and General Counsel Jun 01 '26 Option Exercise 0.00 22,830 0 39,939 Jun 02 05:14 PM Collins Cynthia Director May 14 '26 Option Exercise 0.00 15,757 0 51,846 May 15 04:31 PM Reynders John V W Chief Financial Officer May 14 '26 Option Exercise 0.00 15,757 0 26,466 May 15 04:29 PM BROSHY ERAN Chairman May 14 '26 Option Exercise 0.00 15,757 0 50,708 May 15 04:28 PM Bedi Arjun Director May 14 '26 Option Exercise 0.00 5,547 0 5,547 May 15 04:28 PM CASHMAN JAMES E III Chairman May 14 '26 Option Exercise 0.00 15,757 0 484,197 May 15 04:27 PM Killefer Nancy Director May 14 '26 Option Exercise 0.00 15,757 0 51,846 May 15 04:26 PM Crane Rosemary A Director May 14 '26 Option Exercise 0.00 15,757 0 45,672 May 15 04:26 PM WALSH MATTHEW M Director May 14 '26 Option Exercise 0.00 15,757 0 213,316 May 15 04:25 PM Resnick Jon Matthew Chief Executive Officer May 11 '26 Option Exercise 0.00 59,766 0 59,766 May 13 04:53 PM Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF Apr 01 '26 Option Exercise 0.00 33,167 0 113,744 Apr 03 04:11 PM McKemey Adrian President, Drug Dev. Solutions Apr 01 '26 Option Exercise 0.00 10,849 0 10,849 Apr 03 04:10 PM Corcoran Daniel SVP and General Counsel Apr 01 '26 Option Exercise 0.00 10,849 0 27,070 Apr 03 04:09 PM Gallagher John E Chief Financial Officer Apr 01 '26 Option Exercise 0.00 50,605 0 103,174 Apr 03 04:07 PM Aspbury Robert PRESIDENT, PREDICTIVE TECH Apr 01 '26 Option Exercise 0.00 33,167 0 339,581 Apr 03 04:06 PM Anhalt Rona Chief Human Resources Officer Apr 01 '26 Option Exercise 0.00 9,764 0 14,945 Apr 03 04:04 PM Feehery William F CHIEF EXECUTIVE OFFICER Nov 11 '25 Buy 8.30 24,096 200,000 2,360,769 Nov 12 04:44 PM
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Radnor, PA.
President of Certara Predictive Technologies Dr. Robert P. Aspbury Ph.D.
Senior Advisor Mr. Leif E. Pedersen
President of Drug Development Solutions Dr. Adrian K. McKemey Ph.D.
CEO & Director Mr. Jon Resnick
President & Chief Commercial Officer Mr. Julien Perrier